Number Of Arrow Surgical Wire Problems In Australia Expanded
This article was originally published in PharmAsia News
Executive Summary
A scare in Australia over an implanted medical wire has added to original estimates 200 children might be affected. The wire in question is a peripheral inserted central catheter line to administer chemotherapy drugs and antibiotics. More than 330 Australian families have contacted a hotline established after it was discovered some of the surgical wires have lodged close to the hearts of children. The wires at issue, made by Arrow International, a U.S-based company, have been banned from use in Australia pending an investigation of the cases centered in Queensland hospitals where the PICs have been used for the past year. (Click here for more
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.